Belgium
Université libre de Bruxelles, Center for Diabetes, Research
- Mariana Igoillo Esteve, PhD - Mechanisms of Monogenic Diabetes, GLP-1 treatment for Wolfram syndrome
- Miriam Cnop MD, PhD - Beta cell dysfunction and Monogenic Diabetes, GLP-1 clinical trial for Wolfram syndrome
KU Leuven
- Catherine Verfaillie, MD - (SCIL) creating models for neurodegenerative disorders to allow study of mechanisms underlying neurodegeneration
- Geert Bultynck, PhD - Calcium signaling in WFS1 knockout cells (LCMS)
- Lieve Moons, PhD - molecular mechanisms underlying neural circuit development, neuroinflammation, neuronal survival and regeneration
- Jan Parys - Laboratory of Cellular and Molecular Signaling (LCMS)
Denmark
University of Copenhagen
- Lisbeth Tranebjærg, MD, PhD - Genetics of Wolfram syndrome
Estonia
University of Tartu, Tartu, Estonia -Institute of Biomedicine and Translational Medicine
- Mario Plaas, PhD - Rodent models of Wolfram syndrome, GLP-1 treatment for Wolfram syndrome
- Eero Vasar, MD, PhD - Molecular mechanisms of Wolfram syndrome
Tartu University Children's Hospital, Tartu, Estonia
- Vallo Tillmann, MD - Diabetes and endocrine issues in Wolfram syndrome, Pediatric endocrinology
Finland
University of Helsinki, Finland
- Mart Saarma, PhD - signaling and biological functions of GDNF family ligands and endoplasmic reticulum located CDNF/MANF neurotrophic factor families
- Maria Lindahl, PhD - Genetics, cell and molecular biology
France
Molecular Mechanisms in Neurodegenerative Diseases, University of Montpellier, EPHE, Montpellier, France
- Benjamin Delprat, PhD - Therapeutic development (gene therapy, drug development), iPSC, rodent and zebrafish models, Molecular mechanisms
INSERM - Institute of Neurosciences of Montpellier
- Cécile Delettre, PhD - ER-mitochondria and Wolfram syndrome, mechanisms of visual impairment, gene therapy, pathophysiology and therapy of inherited optic neuropathies
Université Côte d’Azur, CHU, Inserm, CNRS, IRCAN, France
- Véronique Paquis-Flucklinger,MD, PhD - Genetics of Wolfram syndrome
- Laetitia Aubry, PhD - study of the therapeutic application potentials of iPSCs in Wolfram Syndrome
I-STEM - Evry, France
Germany
Centrum für Reproduktionsmedizin und Andrologie,
WHO Kollaborationszentrum, EAA, Ausbildungszentrum, Universitätsklinikum Münster
WHO Kollaborationszentrum, EAA, Ausbildungszentrum, Universitätsklinikum Münster
- Julia Rohayem, MD, PhD - Pediatric Endocrinology with expertise in Wolfram syndrome, Andrology
Israel
Hadassah Medical Center
- Gil Leibowitz, MD - Senior physician in Endocrinology and Metabolism, Beta-cell ER stress and function
Italy
Università degli Studi di Messina - Messina, Italy
- Luciana Rigoli, MD - Departments of Pediatrics, Molecular Biology, Endocrinology
Japan
University of Yamaguchi
- Yukio Tanizawa, MD, PhD - Biology of pancreatic Beta Cells, research in GLP-1 receptor signaling, ER stress and beta cell function
Poland
Medical University of Lodz
- Wojciech Mlynarski, MD, PhD - Genetic forms of diabetes, head of Department of pediatric oncology, hematology and diabetology
Spain
Servicio Andaluz de Salud
- Gema Esteban Bueno, MD - Coordinator of multidisciplinary team for Wolfram syndrome
Laboratorio de Genética Molecular, IDIBELL, l’Hospitalet de Llobregat, Barcelona, Spain
- Miguel López de Heredia, PhD - Studies molecular mechanisms and genotype-phenotype correlations in Wolfram syndrome and cystinuria
- Virginia Nunes, PhD - Cancer and human molecular genetics
Department of Biochemistry and Molecular Biology, Institut de Neurociències, Universitat Autonòma de Barcelona
- Assumpció Bosch, PhD - Expert in gene therapy for rare diseases affecting the nervous system using preclinical models and AAV vectors.
United Kingdom
University of Birmingham
- Timothy Barrett, MD, PhD - PI of an international randomised controlled trial of repurposed therapy in Wolfram syndrome, performs functional genetic studies and translational research with inherited forms of diabetes
University of Cambridge
- Patrick Yu-Wai-Man - Academic neuro-ophthalmologist with specialist research interest in genetic treatment for mitochondrial eye disorders and WS vision loss
United States
Washington University School of Medicine
- Fumihiko Urano, MD, PhD. - Therapeutic development (regenerative therapy, gene therapy, drug development), iPSC and rodent models, Medical Genetics, Genetic testing, Molecular mechanisms
- Tamara Hershey, PhD. - Neuroimaging of patients with Wolfram syndrome, WU Wolfram Research Clinic
- Bess Marshall, MD - Diabetes and endocrine issues in Wolfram syndrome, Pediatric endocrinology
- Angela Reiersen, MD - Psychiatric Diagnoses in Wolfram syndrome, Child and adolescent psychiatric disorders, Neuropsychiatric Genetics
- Neil White, MD - Diabetes and endocrine issues in Wolfram syndrome, Pediatric endocrinology
NCATS/NIH
- Mark Henderson, PhD - Collaborates with both academic and NIH investigators on projects that aim to identify small molecules that can be used to understand and/or modulate pathogenic events
- Anton Simeonov, PhD - Scientific director at NCATS, novel detection chemistries and techniques
Yale University
- Barbara Ehrlich PhD - Professor of Pharmacology and of Cellular And Molecular Physiology, Study of cell mechanisms for regulation of intracellular calcium concentration
University of Chicago
- Louis Philipson, MD, PhD - endocrinologist and a leading world authority on diabetes mellitus
Columbia University
- Wendy Chung, MD, PhD - Clinical Molecular Genetics and Genomics
- Rudolph Leibel, MD - Clinical Molecular Genetics and Genomics
- Dieter Egli, PhD - study of stem cell derived human beta cells, study of pluripotent stem cells
University of Kansas Medical Center
- Hao Zhu, PhD - CISD2 research
